US › Healthcare

Spectral AI Inc. (MDAI)

US · Healthcare · Medical Devices

$1.65+2.48%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$4.0M
Revenue YoY
-40.5%
Net profit
$-3.4M
Profit YoY
-217.8%
EPS
$-0.11
EPS estimate
$-0.07
Net margin
-85.5%

EPS came in at -0.11 against a street estimate of -0.07 — a miss of 53.4%.

Key statistics

Market cap
$49.3M
Forward P/E
52.4
P/B
26.08
Book value
$-0.28
EPS (TTM)
$-0.53
52-week high
$2.97
52-week low
$1.18
50-day MA
$1.84
200-day MA
$1.75
Beta
1.17

Analyst view

Analysts rate Spectral AI Inc. a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $5.12.

Shareholding

Insiders
12.97%
Institutions
15.20%

Largest institutional holders

FundStake
Highlander Partners, L.P.2.83%
Vanguard Capital Management, LLC2.28%
Geode Capital Management, LLC0.95%
Jane Street Group LLC0.69%
University Of Texas Investment Mgmt Co0.66%
Bridgeway Capital Management, LLC0.63%
Vanguard Fiduciary Trust Co0.45%
BlackRock Inc0.38%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Spectral AI Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.